Columns
- All
- Advanced Degrees
- Analyze This
- Back Page
- Clinically Speaking
- Data Integrity
- Deal Discussions
- Editorial
- Emerging Markets
- Executive Perspective
- FDA Watch
- Financial Analysis
- Getting Results
- I Mak
- India Report
- Lowe Down
- Managing Your Career
- Newsmakers Interviews
- Opinions & Best Practices
- PBOA News
- Pharma Beat
- Preclinical Outsourcing
- The BioPharm Insider
-
The Pandemic’s Become an Insurmountable Opportunity
Every Cloud has a Silver Lining(?)Emil W. Ciurczak, Contributing Editor 10.14.20
-
The Changing Approach to Design: Five Ways to Achieve Warp Speed
Revisiting facility design and construction based on today’s biopharmaceutical industry needs.Jarrod Wrampe, Contributing Editor 10.14.20
-
The Art and Science of Recruitment
Chapter Two: Building Word-of-Mouth Via Networking.David G. Jensen, Contributing Editor 10.14.20
-
Biologics, Proteins, Vaccines | Biosimilars | R&D
The Global Biotech Boom
How an industry grew to lead health care innovation and how CROs are adapting to meet their needs.Davide Garrisi, PPD Biotech 09.09.20
-
Supply Chain Woes Vex Markets
Indian players ramp up chloroquine productionS. Harachand, Contributing Editor 09.09.20
-
Biologics, Proteins, Vaccines | Regulatory Affairs
Ensuring Manufacturing Continuity for Essential Medicines
Applying the principles of Quality Risk Management to get medicines to market faster.John Darby, M.Sc., Senior Director, Lachman Consultant Services, Inc. 09.09.20
-
Biologics, Proteins, Vaccines
![It Takes a Vaccine… To End The Pandemic [У нас есть хорошая вакцина]](https://dev.rodpub.com/images/218/898_thumb.jpg)
It Takes a Vaccine… To End The Pandemic [У нас есть хорошая вакцина]
Race for the vaccines is heating up.Ben Locwin, Contributing Editor 09.09.20
-
The Art and Science of Recruitment
Chapter One: Define your need. Craft your message.David G. Jensen, Contributing Editor 09.09.20
-
The Ongoing Impact of COVID-19
Contract Pharma’s Conference Web Series kicks off Sept. 23 and features COVID-19-themed sessions.Tim Wright, Editor 09.09.20
-
The “Three Cs” of C(D)MO Selection
Plus, what does it take for contract organizations to fall in the “Goldilocks” zone for pharmaceutical companies?Valdas Jurkauskas, Ph.D., Akebia Therapeutics 07.15.20
-
Biologics, Proteins, Vaccines
Pharma’s Fight Against the Coronavirus Pandemic
A look at the pharma industry’s concerted effort to develop vaccines against the SARS-CoV-2 virus and therapeutics to treat COVID-19.Keith O. Webber, Lachman Consultant Services, Inc. 07.15.20
-
Top 25 Pharma & Biopharma
Combined pharma sales for the 2020 Top Companies came close to $650 billion.Tim Wright, Editor 07.15.20
-
cGMP Manufacture
Keys to Biotech Success
Four steps emerging biotech companies can take to achieve successThierry Cournez, Head of End-to-End Solutions, MilliporeSigma 06.04.20
-
The New Wave of Innovation
Cell and gene therapies delivering on the promise of precision medicineTim Wright, Editor 06.04.20
-
Analytical Services
What Happens When the All-Clear Signal is Given?
Maybe 3M had some good ideas?Emil W. Ciurczak, DoraMaxx Consulting 06.04.20
-
Speeding Vaccine Development with Advanced Analytics
Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development processDr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 05.05.20
-
HCQ Comes Center Stage
Indian players ramp up chloroquine productionS. Harachand, Contributing Editor 05.05.20
-
-
Rapid Delivery of Medical Countermeasures Amid Pandemic
Robert Erwin of iBio discusses the company’s COVID-19 vaccine development efforts and FastPharming manufacturing platform for the rapid delivery of vaccinesKristin Brooks, Managing Editor, Contract Pharma 05.05.20
-
Information Technology | Regulatory Affairs
Data Integrity: Beyond Electronic Records
Get your Data Integrity house in orderTim Rhines, Ph.D., Director, Lachman Consultant Services, Inc. 05.05.20
